Step 1: CHECK if you suspect an overdose CHECK for a suspected overdose : the person will not wake up or is very sleepy or not breathing well yell “Wake up!” shake the person gently if the person is not awake, go to Step 2 Step 2: GIVE 1st dose in the nose HOLD the nasal spray device with your thumb on the bottom of the plunger INSERT the nozzle into either NOSTRIL PRESS the plunger firmly to give the 1st...
CHECK for a suspected overdose: the person will not wake up
or is very sleepy or not breathing well
yell “Wake up!”
shake the person gently
if the person is not awake, go to Step 2
step 2
Step 2: GIVE 1st dose in the nose
HOLD the nasal spray device with your thumb on the bottom
of the plunger
INSERT the nozzle into either NOSTRIL
PRESS the plunger firmly to give the 1st dose
1 nasal spray device contains 1 dose
step 3
Step 3: CALL 911
CALL 911 immediately after giving the 1st dose
step 4
Step 4: WATCH AND GIVE
WAIT 2 to 3 minutes after the 1st dose to give the medicine time to work
if the person wakes up: Go to Step 5
if the person does not wake up:
CONTINUE TO GIVE doses every 2 to 3 minutes until the person
wakes up
it is safe to keep giving doses
step 5
Step 5: STAY
STAY until ambulance arrives: even if the person wakes up
GIVE another dose if the person becomes very sleepy again
You may need to give all the doses in the pack
For opioid emergencies, call 911.For questions or more information about Naloxone Hydrochloride Nasal Spray, contact Amneal Pharmaceuticals at 1-877-835-5472.
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.